Expression of Adenosine Deaminase and NLRP3 Inflammasome in Tuberculous Peritonitis and Their Relationship with Clinical Efficacy

Figure 4

Relationship between ADA, NLRP3, and adverse reactions (a). Comparison of ADA of patients with and without adverse reactions before treatment. (b) Comparison of NLRP3 of patients with and without adverse reactions before treatment. (c) ROC curve of ADA predicting adverse reactions of TP patients before treatment. (d) ROC curve of NLRP3 predicting adverse reactions of TP patients before treatment. (e) ROC curve of ADA combined with NLRP3 predicting adverse reactions of TP patients before treatment. ^#.

(a)

(b)

(c)

(d)

(e)